StimLabs Unveils Corplex P to Enhance Wound Management
StimLabs, a leader in regenerative medicine, has recently announced the nationwide launch of its innovative product, Corplex P. This groundbreaking medical device is specifically designed to aid in the management of hard-to-heal wounds, ranging from chronic to acute types.
Understanding Corplex P
Corplex P is a dehydrated human umbilical cord particulate (dHUCP) device that has set a new standard in wound care. This unique formulation is derived from human umbilical cord extracellular matrix (ECM), marking it as the first of its kind to receive specific FDA clearance for wound management.
Composition and Functionality
The formulation of Corplex P includes crucial connective tissue components like collagens, fibronectin, and glycosaminoglycans (GAGs). Unlike many products available on the market, Corplex P uses a proprietary processing method that preserves these vital elements, ensuring maximum efficacy. Particularly, its hydrophilic components, including hyaluronic acid, play an essential role in creating an optimal moist wound environment.
Versatile Wound Management Solution
Corplex P is engineered to handle a wide array of wound types, including pressure ulcers, diabetic ulcers, and surgical wounds, ensuring comprehensive care for patients with diverse needs. This versatility is further enhanced by its particulate format, which promotes effective moisture management and wound integration.
Testimonials and Endorsements
According to John Daniel, Founder and CEO of StimLabs, "Chronic and acute wounds are a significant health challenge for many individuals. With Corplex P, we are not just offering a product; we are providing clinicians the tools to enhance patient care and quality of life. The feedback from healthcare practitioners has been overwhelmingly positive, and we are thrilled to make this available nationwide."
Dr. Jamison Feramisco, MD, PhD, also praised the product, stating, "StimLabs has introduced a revolutionary human tissue-derived device to the market. The flexibility of Corplex P allows for tailored application, optimizing treatment outcomes for my patients with complex wounds. This innovation is a vital addition to my treatment protocols for hard-to-heal wounds."
Where to Find Corplex P
Corplex P is now available for healthcare providers and can be utilized in various settings, including hospitals. It will also be showcased at significant events like the upcoming Symposium on Advanced Wound Care (SAWC) Fall Conference, offering clinicians firsthand experience with the product through workshops and presentations.
About StimLabs
Founded in 2015, StimLabs LLC is dedicated to advancing regenerative medicine. The company, backed by industry experts, strives to provide innovative solutions and personalized care through a diverse product range. Recognized for its commitment to excellence, StimLabs has built a robust intellectual property portfolio and continues to be a trusted partner for healthcare professionals and patients alike.
Frequently Asked Questions
What is Corplex P?
Corplex P is a medical device designed for the management of hard-to-heal wounds, derived from human umbilical cord extracellular matrix.
What types of wounds can Corplex P treat?
Corplex P is effective for various wound types, including pressure ulcers, diabetic ulcers, and surgical wounds.
How does Corplex P function?
Corplex P creates a moist wound environment and is designed to enhance moisture regulation, supporting optimal healing conditions.
Where can I learn more about Corplex P?
For detailed information on Corplex P, visit StimLabs' official website.
Who is behind StimLabs?
StimLabs LLC was founded by industry leaders committed to advancing the field of regenerative medicine and improving patient care through innovative solutions.
